中国临床球形孢子丝菌菌丝相药物敏感性分析

中国真菌学杂志　 2016, Vol. 11 　Issue (4): 209-212.

中国临床球形孢子丝菌菌丝相药物敏感性分析

贺羽¹, 黄宜进², 赵秘密¹, 周汛^1,3

1. 重庆医科大学附属第一医院皮肤科, 重庆 400016;
2. 四川省南部县人民医院, 南充 637300;
3. 重庆市中医院皮肤美容科, 重庆 400021

收稿日期:2015-09-29 出版日期:2016-08-28 发布日期:2016-08-28
通讯作者: 周汛,E-mail:zhouxun123@sina.com E-mail:zhouxun123@sina.com
作者简介:贺羽,女(汉族),硕士研究生在读.E-mail:15123825300@163.com
基金资助:
国家自然科学基金（31270062）

In vitro antifungal susceptibilities of mycelium phase of Sporothrix globosa in China

HE Yu¹, HUANG Yi-jin², ZHAO Mi-mi¹, ZHOU Xun^1,3

1. Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China;
2. People's Hospital of Nanbu Prefecture of Sichuan, Nanchong 637300, China;
3. Department of Dermatology and Cosmetology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400021, China

Received:2015-09-29 Online:2016-08-28 Published:2016-08-28

摘要/Abstract

摘要：

目的检测我国临床球形孢子丝菌菌丝相对5种抗真菌药物的体外敏感性，同时对比我国不同地区菌株药物敏感性的差异。方法将重庆、吉林、北京地区既往基因鉴定为球形孢子丝菌的100株临床菌株接种于2%马铃薯葡萄糖琼脂培养基（PDA）上，25℃恒温培养7 d获得菌丝相。依据美国临床与实验室标准化委员会（CLSI）制定的M38-A2方案，采用微量液基稀释法检测菌丝相对碘化钾、伊曲康唑、特比萘芬、氟康唑、两性霉素B的体外最低抑菌浓度（MIC）。质控菌株为近平滑念菌ATCC22019。结果碘化钾体外无抗真菌活性，特比萘芬MIC几何均值为0.14 μg/mL，伊曲康唑和两性霉素B MIC几何均值分别为0.79 μg/mL和0.63 μg/mL，氟康唑MIC几何均值为45.89 μg/mL。发现7株对伊曲康唑耐药菌株，吉林地区相对较多，但不同地区菌株的药物MIC值差异无统计学意义（P>0.05）。结论碘化钾无体外抗真菌活性，我国临床球形孢子丝菌对特比萘芬最敏感，其次为伊曲康唑和两性霉素B，对氟康唑敏感性最差，不同地区菌株对抗真菌药物的敏感性没有明显差异。

关键词: 球形孢子丝菌, 菌丝相, 药敏实验, 微量液基稀释法

Abstract:

Objective To investigate the activities of five antifungal agents on mycelia form of Sporothrix globosa and compare the differences in antifungal susceptibilities in different areas of China.Methods Total 100 isolates which were identified as Sporothrix globosa by molecular identification from Chongqing,Beijing and Jilin were subcultured on 2% potato-dextrose agar plates at 25℃ for 7 d.Then according to modified CLSI microdilution method M38-A2,MICS were measured to evaluate the antifungal activities of potassium iodide(KI),itraconazole(ITC),terbinafin(TRB),fluconazole(FLC),amphotericin B(AmB) to these isolates in vitro.Candida parapsilosis ATCC22019 was used as quality control.Results Potassium iodide showed no antifungal activity against any Sporothrix globosa isolates.TRB gave the lowest geometric mean(GM=0.14 μg/mL) MIC.ITC and AmB showed almost the same activity against all strains tested and the GM was 0.79 μg/mL and 0.63 μg/mL respectively.FLC gave the highest GM MIC(45.89 μg/mL).Seven isolates(four from Jilin,two from Chongqing,one from beijing) were found to be itraconazole-resistant,There was no difference in susceptibility according to the geographical source of the isolates(P>0.05).Conclusion Potassium iodide showed no antifungal activities in vitro.TRB was the most active drug,followed by the ITC and AmB.FLC was the least effective drug.There was no difference in antifungal susceptibilities in different areas of China.

Key words: Sporothrix globosa, mycelium phase, antifungal susceptibility test, micro-broth dilution method

中图分类号:

R379.9

贺羽, 黄宜进, 赵秘密, 周汛. 中国临床球形孢子丝菌菌丝相药物敏感性分析[J]. 中国真菌学杂志, 2016, 11(4): 209-212.

HE Yu, HUANG Yi-jin, ZHAO Mi-mi, ZHOU Xun. In vitro antifungal susceptibilities of mycelium phase of Sporothrix globosa in China[J]. Chinese Journal of Mycology, 2016, 11(4): 209-212.

参考文献

[1] Tellez MD,Batista-Duharte A,Portuondo D,et al.Sporothrix schenckii complex biology:environment and fungal pathogenicity[J].Microbiology,2014,160(11):2352-2365.
[2] Marimon R,Gene J,Cano J,et al.Molecular phylogeny of Sporothrix schenckii[J].J Clin Microbiol,2006,44(9):3251-3256.
[3] 谭静文,刘伟,万喆,等.来自中国北方部分地区33株孢子丝菌菌株的表型和基因型鉴定[J].菌物学报,2013,32(2):161-167.
[4] Yu X,Wan Z,Zhang Z,et al.Phenotypic and molecular identification of Sporothrix isolates of clinical origin in Northeast China[J].Mycopathologia,2013,176(1-2):67-74.
[5] Mahajan VK.Sporotrichosis:an overview and therapeutic options[J].Dermatol Res Pract,2014,2014(2013):272376.
[6] Ottonelli Stopiglia CD,Magagnin CM,Castrillon MR,et al.Antifungal susceptibilities and identification of species of the Sporothrix schenckii complex isolated in Brazil[J].Med Mycol,2014,52(1):56-64.
[7] 王润超,王爱平,万喆,等.特比萘芬联合伊曲康唑治疗孢子丝菌病失败1例[J].中国真菌学杂志,2013,8(5):294-296.
[8] Kauffman CA,Bustamante B,Chapman SW et al,Clinical practice guidelines for the management of sporotrichosis:2007 update by the Infectious Diseases Society of America[J].Clin Infect Dis,2007,45(10):1255-1265.
[9] Stopiglia,CD,Marchese DP,Heidrich D,et al,Comparison between two culture media for in vitro evaluation of antifungal susceptibility of the Sporothrix schenckii complex[J].An Bras Dermatol,2012,87(4):561-565.
[10] 刘锦燕,项明洁.抗真菌药物敏感性试验方法研究进展[J].中国感染与化疗杂志,2009,24(12):927-931.
[11] Kohler LM,Soares BM,de Assis Santos D,et al.In vitro susceptibility of isolates of Sporothrix schenckii to amphotericin B,itraconazole,and terbinafine:comparison of yeast and mycelial forms[J].Can J Microbiol,2006,52(9):843-847.
[12] 薛汝增,张静,黄怀球.申克孢子丝菌体外药敏试验研究进展[J].中国真菌学杂志,2008,3(06):372-374.
[13] 张晓冬,张艳,徐莉.E-test法和Rosco纸片法检测申克孢子丝菌对伊曲康唑和氟康唑的敏感性试验[J].中国皮肤性病学杂志,2010,24(11):992-993.
[14] Borba-Santos LP,Rodrigues AM,Gagini TB,et al.Susceptibility of Sporothrix brasiliensis isolates to amphotericin B,azoles,and terbinafine[J].Med Mycol,2015,53(2):178-188.
[15] Chapman SW,Pappas P,Kauffmann C,et al.Comparative evaluation of the efficacy and safety of two doses of terbinafine(500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis[J].Mycoses,2004,47(1-2):62-68.
[16] Marimon R,Gene J,Cano J,et al.In vitro antifungal susceptibilities of five species of Sporothrix[J].Antimicrob Agents Chemother,2008,52(2):732-734.
[17] Song Y,Li SS,Zhong SX,et al.Report of 457 sporotrichosis cases from Jilin province,northeast China,a serious endemic region[J].J Eur Acad Dermatol Venereol,2013,27(3):313-318.
[18] Silveira CP,Torres-Rodriguez JM,Alvarado-Ramirez,et al,MICs and minimum fungicidal concentrations of amphotericin B,itraconazole,posaconazole and terbinafine in Sporothrix schenckii[J].J Med Microbiol,2009,58(12):1607-1610.
[19] Trilles L,Fernandez-Torres B,Wanke B,et al.In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases[J].Antimicrob Agents Chemother,2005,49(9):3952-3954.
[20] Crothers SL,White SD,Ihrke PJ,et al.Sporotrichosis:a retrospective evaluation of 23 cases seen in northern California(1987-2007)[J].Vet Dermatol,2009,20(4):249-259.
[21] 张晓冬,徐莉,张莉敏.氟康唑治疗孢子丝菌病的临床疗效及体外抗真菌药敏试验研究[J].中国皮肤性病学杂志,2010,24(2):129-130.
[22] Coskun B,Saral Y,Akpolat N,et al.Sporotrichosis successfully treated with terbinafine and potassium iodide:case report and review of the literature[J].Mycopathologia,2004,158(1):53-56.
[23] Hiruma M,Kagawa S.Ultrastructure of Sporothrix schenckii treated with iodine-potassium iodide solution[J].Mycopathologia,1987,97(2):121-127.